Abeona Therapeutics (ABEO) Short-term Investments (2011 - 2026)

Abeona Therapeutics' Short-term Investments history runs 11 years deep, the most recent figure standing at $106.9 million for Q1 2026.

• In Q1 2026, Short-term Investments rose 56.7% year-over-year to $106.9 million; the TTM figure through Mar 2026 stood at $106.9 million (up 56.7% YoY), while the FY2025 annual figure was $113.0 million, up 51.91% from the prior year.
• Short-term Investments for Q1 2026 stood at $106.9 million, down from $113.0 million in the prior quarter.
• The five-year high for Short-term Investments was $124.2 million in Q3 2025, with the low at $11.0 million in Q1 2022.
• The 5-year median for Short-term Investments is $49.0 million (2023), against an average of $59.1 million.
• The sharpest annual moves came in 2022 and 2023: Short-term Investments sank 84.84% in 2022, then soared 294.42% in 2023.
• Abeona Therapeutics' Short-term Investments stood at $37.9 million in 2022, then fell by 0.47% to $37.8 million in 2023, then soared by 96.97% to $74.4 million in 2024, then jumped by 51.91% to $113.0 million in 2025, then declined by 5.37% to $106.9 million in 2026.
• Business Quant data shows ABEO's Short-term Investments at $106.9 million in Q1 2026, $113.0 million in Q4 2025, and $124.2 million in Q3 2025.